Medical Device and Diagnostic Industry (MDDI)

MD&DI is a specialized magazine focused on the medical device and diagnostic sector, published by UBM Canon based in Los Angeles. The magazine features peer-reviewed articles that tackle various technological challenges, as well as summaries of important business, industry, and regulatory matters. Since its founding in 1979, MD&DI has evolved from a print publication, which had a monthly circulation of 48,040 in 2009, to a fully online platform boasting a claimed readership of 89,000.

National, Trade/B2B

English

Magazine

Outlet metrics

Domain Authority

Ranking

Global

#468307

United States

#203855

Health/Health

#3905

Traffic sources

Monthly visitors

Articles

MedTech Europe Wants Tariff & Export Exemptions

1 week ago | mddionline.com | Omar Ford

MedTech Europe is calling on European policymakers to exempt medical technologies from any trade tariffs or export restrictions. The measure comes in response to the European Commission closing its public consultation on a list of EU countermeasures that could be applied to both imports from and exports to the United States, paving the way for a second package of retaliatory measures.
Cancer Testing Company Caris Goes Public in $494M IPO

1 week ago | mddionline.com | Amanda Pedersen

Personalised advertising and content, advertising and content measurement, audience research and services developmentStore and/or access information on a deviceYou can choose how your personal data is used.
Enlil Gets to the Heart of What Matters for Medtech Innovators

1 week ago | mddionline.com | Omar Ford

At a GlanceBorn from Shifamed's innovation hub, Enlil delivers enterprise-grade compliance tools in a scalable platform. Enlil's solution addresses pain points by replacing fragmented spreadsheets with paper records with a centralized system. Enlil was founded to solve a critical challenge for medical device innovators: efficiently navigating regulated product development without being hindered by disconnected systems, manual processes, or enterprise-level costs.
14 Private Medical Device Companies Raising the Bar

1 week ago | mddionline.com | Amanda Pedersen

Amanda Pedersen is a veteran journalist and award-winning columnist with a passion for helping medical device professionals connect the dots between the medtech news of the day and the bigger picture. She has been covering the medtech industry since 2006. Amanda's weekly op-ed, Pedersen's POV, was a 2023 Neal Awards Winner for "Best Commentary," a 2024 Neal Awards finalist for "Best Commentary," and a 2025 Neal Awards Winner for "Best Commentary."Amanda Pedersen poses with her Jesse H.
Does Medtech's Misogyny Problem Linger?

1 week ago | mddionline.com | Amanda Pedersen

In 2014, MD+DI editors had good reason to call out medtech's misogyny problem. This week's Trivia Tuesday question asks: Does medtech's misogyny problem linger 11 years later? It seemed like a relatively innocuous question when MD+DI asked the medtech community back in 2014 for nominations of women researchers, engineers, and designers driving innovation in the field.
Thermo Fisher Scientific Could Divest Diagnostics Division for More than $4B

1 week ago | mddionline.com | Omar Ford

The rumored deal comes a few months after the Waltham, MA-based company said it would acquire Solventum’s Purification & Filtration unit in a deal valued at $4.1 billion. Thermo Fisher Scientific is putting up part of its diagnostics unit for sale, in the latest installment of larger medtech companies shedding low-performing units, according to a report from the Financial Times.
Abbott’s Freestyle Libre Shown to Reduce Hospitalizations for Heart Complications in Diabetic Patients

1 week ago | mddionline.com | Susan Shepard

Data from Abbott’s REFLECT study show for the first time that the use of its continuous glucose monitoring technology, Freestyle Libre, can help lessen the severity of cardiovascular complications in Type 1 diabetics. The study considered a range of cardiovascular ailments, including nonfatal heart attack, nonfatal stroke, coronary artery disease, heart failure, atrial fibrillation, and cardiovascular death. These are conditions commonly seen in people with diabetes.
The Tylenol Murders' Lasting Impact on Medical Packaging

1 week ago | mddionline.com | Amanda Pedersen

PackagingThis week in Pedersen's POV, our senior editor explores how the Tylenol murders fundamentally changed how consumer medical products are packaged in the United States. In September 1982, seven people in the Chicago area between the ages of 12 and 35 were murdered after taking Cyanide-contaminated Extra Strength Tylenol. My own relationship with the Tylenol brand began under different but equally dangerous circumstances.
Medtronic Faces Ventilator Recall

1 week ago | mddionline.com | Omar Ford

Medtronic has issued a voluntary recall related to its Newport HT70 and HT70 Plus ventilators and certain related Newport service parts. FDA has designated the voluntary action by the Dublin-based company as a Class I recall. With this recall, Medtronic is advising the discontinuation of clinical use of the affected devices. Investigation into customer complaints identified two separate capacitors on one of the ventilator’s controllers, Printed Circuit Board Assembly (PCBA).
Medtronic Diabetes Spinoff to Honor MiniMed Roots

2 weeks ago | mddionline.com | Amanda Pedersen

When Key Payton was just three years old, doctors told his parents he likely wouldn’t live past 10. And yet, 65 years later, he says he is defying the odds and living his best life. “I’ve experienced firsthand how the company has transformed diabetes care and personally helped me beat those early odds in astounding ways,” said Payton, a Medtronic employee. “I’m forever grateful for the hope and support they’ve given me every day for nearly three decades.